news
Operation Yellowhammer file confirms drug shortages after no-deal Brexit
The Operation Yellowhammer document has been published, which states that the UK will experience severe delays to the medical supply chain following a no-deal Brexit.
List view / Grid view
Drug Supply Chain
news
Federal judge enters consent decree against drug distributors
Two Tennessee companies have been prevented from distributing drugs after a complaint they were supplying unapproved medications.
news
Pakistan lifts Indian import ban for essential medications
A ban on Indian trade to Pakistan has been partly changed to allow the import of drugs after a shortage of critical medicine.
news
NICE recommends voretigene neparvovec for use on NHS
The voretigene neparvovec gene therapy treatment has been highlighted in draft guidance by NICE for availability on the NHS.
article
China and the evolving regulatory landscape
The Chinese pharmaceutical industry has been lagging behind in terms of drug development and bringing new products to the market. In this article, Megha Baruah discusses the changes the National Medical Products Administration (NMPA) of China is making to existing policies and informs on guidance documents that have been released…
article
The future of tamper-proof pharmaceutical packaging
In February this year the EU Falsified Medicines Directive (FMD) came into effect. Rich Quelch assesses this latest regulatory attempt to rid the supply chain of dangerous falsified products and reflects on the industry’s need to keep ahead of the game to future-protect itself.
article
Manufacturing, Packaging & Logistics In-Depth Focus 2019
The articles in this In-Depth Focus delve into the effectiveness of the FMD and why it is necessary as well as how drug manufacturers need to become innovative in their processes.
news
Health union leaders warn of medicine shortages in event of no-deal Brexit
A statement from 11 health union leaders highlights the possibility of severe drug shortages if the UK leaves the EU without a deal.
news
China to relax generic drug import laws
The government in China has stated that small quantities of generic medicines that are legal in foreign countries will no longer be classed as “fake drugs”.
news
HRT shortage in UK expected to continue until next year
Around half of HRT products have been reported as out of stock in UK pharmacies due to supply issues in China, leading to a shortage.
news
Leaked government document reveals possibility of no-deal Brexit drug shortages
A leaked government dossier has stated that in the event of a no-deal Brexit, the UK will face severe medicinal shortages.
news
Drug supplier Aspen to pay NHS £8m after competition probe
The CMA alleges that Aspen broke competition law, prompting the drug supplier to offer a payment and other compensations to the NHS.
news
Letter highlights issues with US drug returns verification requirements
An open letter has underscored the challenges of return failure in the US drug supply chain, especially after the introduction of the Drug Supply Chain Security Act in November.
article
Climate change: how pharma will profit from a warming planet
Rising temperatures will likely accelerate the spread of vector-borne diseases, resulting in an increased demand for vaccines. European Pharmaceutical Review investigates a Morgan Stanley report on the pharmaceutical beneficiaries of climate change.
news
Swine fever in China raises concern over heparin supply for US
The US supply of heparin, an ingredient used in anticoagulant drugs and found in pigs, is under threat due to an outbreak of disease in Chinese herds.
